-
Catalyst Pharma Plummets On Competition For Pricey LEMS Drug
Tuesday, May 7, 2019 - 11:10am | 524Read More...Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares were sinking Tuesday and trading to their lowest levels since late March, with the downward move attributed to the approval of a drug rivaling its Firdapse. What Happened The FDA announced late Monday it is giving the go-ahead for privately held...
-
Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns
Monday, April 22, 2019 - 10:24am | 568Read More...Eli Lilly And Co (NYSE: LLY) faced a setback following the release of top-line results from a late-stage study of its pain medication candidate. What Happened Lilly and partner Pfizer Inc. (NYSE: PFE) said in a Thursday news release the Phase 3 study intended to evaluate tanezumab...
-
Prothena Plummets 60% After Lead Drug Fails Phase 2 Trial
Monday, April 23, 2018 - 9:39am | 381Read More...Prothena Corporation PLC (NASDAQ: PRTA) plummeted 60 percent Monday morning after a disappointing update relating to the company's treatment for AL amyloidosis. What Happened Prothena, a clinical-stage biopharmaceutical company that focuses on therapies in the neuroscience and orphan...
